Literature DB >> 11944950

A retrospective study comparing the individual modalities of triple assessment in the pre-operative diagnosis of invasive lobular breast carcinoma.

S M Tan1, K A Behranwala, P A Trott, N A Nasiri, E Moskovic, G Brown, D M King, N P M Sacks, G P H Gui, N A Nasim.   

Abstract

AIMS: Early invasive lobular breast carcinoma (ILC) is associated with few symptoms and signs. The individual sensitivity of clinical examination, mammography, ultrasonography, cytology and core biopsy have each been reported to be of limited value. The aim of this study was to evaluate the accuracy of triple assessment in the pre-operative detection of patients identified to have ILC from their surgical pathology.
METHODS: Pure ILC was defined as tumours containing at least 90% lobular features. The triple assessment of 273 patients diagnosed primarily at our institution were reviewed.
RESULTS: 87.5% of women were symptomatic and 12.5% were screen detected. The mean patient age was 59 (range 30-81) years and the median tumour size was 26 (range 5-110) mm. The main mammographic abnormalities were a spiculated lesion (33.3%), an ill-defined mass (33.3%) or architectural distortion (23.5%). The sensitivities for detecting ILC of each modality were: clinical examination (76.6%), mammography (79.8%), ultrasound examination (93.9%), fine-needle aspiration cytology (FNAC) (60.5%) and core biopsy (90.8%). Combining the three modalities of clinical examination, imaging and cyto/pathology increased the pre-operative detection rate of ILC.
CONCLUSION: Triple assessment is useful in the diagnosis of ILC. As the features of ILC may be subtle, a high index of suspicion is required to facilitate early diagnosis. Copyright Harcourt Publishers Limited.

Entities:  

Mesh:

Year:  2002        PMID: 11944950     DOI: 10.1053/ejso.2001.1236

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  6 in total

Review 1.  CDH1 germline mutations and hereditary lobular breast cancer.

Authors:  Giovanni Corso; Mattia Intra; Chiara Trentin; Paolo Veronesi; Viviana Galimberti
Journal:  Fam Cancer       Date:  2016-04       Impact factor: 2.375

2.  Surgical Options and Locoregional Recurrence in Patients Diagnosed with Invasive Lobular Carcinoma of the Breast.

Authors:  Yasuaki Sagara; William T Barry; Melissa Anne Mallory; Ines Vaz-Luis; Fatih Aydogan; Jane E Brock; Eric P Winer; Mehra Golshan; Otto Metzger-Filho
Journal:  Ann Surg Oncol       Date:  2015-04-18       Impact factor: 5.344

3.  Imaging features and conspicuity of invasive lobular carcinomas on digital breast tomosynthesis.

Authors:  Foucauld Chamming's; Ellen Kao; Ann Aldis; Romuald Ferré; Atilla Omeroglu; Caroline Reinhold; Benoit Mesurolle
Journal:  Br J Radiol       Date:  2017-04-03       Impact factor: 3.039

4.  The biology of malignant breast tumors has an impact on the presentation in ultrasound: an analysis of 315 cases.

Authors:  S Wojcinski; N Stefanidou; P Hillemanns; F Degenhardt
Journal:  BMC Womens Health       Date:  2013-11-19       Impact factor: 2.809

5.  Locally advanced invasive lobular carcinoma presenting as skin erythema, with multimodality imaging correlation.

Authors:  Santo Maimone; Miglena K Komforti; Haley P Letter; Kevin J Wu
Journal:  Radiol Case Rep       Date:  2022-08-01

6.  Does fine-needle aspiration biopsy still have a place in the diagnosis of breast lesions?

Authors:  Marzanna Obrzut; Marian Cholewa; Jakub Baran; Agnieszka Obrzut-Palusińska; Ewa Kurczab
Journal:  Prz Menopauzalny       Date:  2018-04-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.